Structural dynamics and kinase inhibitory activity of three generations of tyrosine kinase inhibitors against wild-type, L858R/T790M, and L858R/T790M/C797S forms of EGFR-Reference-Cited by-同舟云学术

Structural dynamics and kinase inhibitory activity of three generations of tyrosine kinase inhibitors against wild-type, L858R/T790M, and L858R/T790M/C797S forms of EGFR

Published:2022-08 Issue: Volume:147 Page:105787
ISSN:0010-4825
Container-title:Computers in Biology and Medicine
language:en
Short-container-title:Computers in Biology and Medicine

Author:

Todsaporn Duangjai,Mahalapbutr Panupong,Poo-arporn Rungtiva P.^ORCID,Choowongkomon Kiattawee^ORCID,Rungrotmongkol Thanyada

Publisher

Elsevier BV

Subject

Health Informatics,Computer Science Applications

Reference105 articles.

1. Osimertinib making a breakthrough in lung cancer targeted therapy;Zhang;OncoTargets Ther.,2016

2. Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update;Bethune;J. Thorac. Dis.,2010

3. Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway;Li;Pharmacol. Res.,2017

4. Targeting drug resistance in EGFR with covalent inhibitors: a structure-based design approach;Engel;J. Med. Chem.,2015

5. Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: comparative pharmacokinetics and drug–drug interactions;Peters;Cancer Treat Rev.,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent developments in receptor tyrosine kinase inhibitors: A promising mainstay in targeted cancer therapy;Medicine in Drug Discovery;2024-09

2. Imidazole[1,5-a]pyridine derivatives as EGFR tyrosine kinase inhibitors unraveled by umbrella sampling and steered molecular dynamics simulations;Scientific Reports;2024-05-28

3. GraphEGFR: Multi‐task and transfer learning based on molecular graph attention mechanism and fingerprints improving inhibitor bioactivity prediction for EGFR family proteins on data scarcity;Journal of Computational Chemistry;2024-05-07

4. Discovery of furopyridine-based compounds as novel inhibitors of Janus kinase 2: In silico and in vitro studies;International Journal of Biological Macromolecules;2024-03

5. Screening of phytochemicals from Clerodendrum inerme (L.) Gaertn as potential anti-breast cancer compounds targeting EGFR: an in-silico approach;Journal of Biomolecular Structure and Dynamics;2023-12-23